{"id":"W2964957864","doi":"10.1007/s10549-019-05360-3","title":"A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche","keywords":"Docetaxel; Taxane; Paclitaxel; Medicine; Adverse effect; Breast cancer; Lung cancer; Cancer; Metastatic breast cancer; Internal medicine; Pharmacology; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001571871,0.001961658,0.002986476,0.0007723438,0.0005452714,0.001304043,0.001045799,0.001405199,0.003869422],"category_scores_gemma":[0.001118112,0.001059047,0.001668693,0.0008766956,0.001883831,0.001523993,0.000424253,0.005699364,0.001072112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001495374,"about_ca_system_score_gemma":0.002269004,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00175292,"about_ca_topic_score_gemma":0.004071071,"domain_scores_codex":[0.9993549,0.0002826974,0.00002530435,0.0001335085,0.0000619272,0.0001417306],"domain_scores_gemma":[0.9990366,0.0001245887,0.0001809773,0.0001326311,0.00004896126,0.0004763339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7932309,0.1073249,0.003239346,0.0004093833,0.001142837,0.0001325589,0.0003008384,0.002738481,0.03167188,0.0003486222,0.002364445,0.05709579],"study_design_scores_gemma":[0.5685245,0.4193978,0.005808885,0.0000181281,0.0003505724,0.0001421012,0.00006448981,0.001255158,0.002501934,0.0002248884,0.001675439,0.00003598989],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943992,0.0008869108,0.0005378342,0.0003147675,0.0001263126,0.001540324,0.0007522518,0.00009940236,0.001342814],"genre_scores_gemma":[0.9899346,0.001353516,0.001676499,0.0007356158,0.0001919973,0.001713262,0.001531402,0.00005497659,0.00280816],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003869422,"threshold_uncertainty_score":0.01294446,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05230859694138998,"score_gpt":0.4250821389585268,"score_spread":0.3727735420171367,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}